Scleral Lens Market Size to Cross USD 982.68 Bn by 2034

The global scleral lens market size was valued at USD 327.04 billion in 2024 and is expected to cross around USD 982.68 billion by 2034, growing at a CAGR of 11.63%.

Get a Free Sample Copy of the Report@ https://www.precedenceresearch.com/sample/5807

Scleral Lens Market Key Points

• North America held the top spot with 41% of the global market share in 2024.

• Asia Pacific is projected to grow at the fastest CAGR through the forecast period.

• Corneo-scleral and semi-scleral lenses led the market by type in 2024.

• Mini-scleral lenses are expected to see the highest growth in the coming years.

• Irregular cornea treatment was the largest application segment in 2024.

• Ocular surface disease applications are forecasted to expand rapidly.

• Eye clinics were the primary end users in 2024.

• Hospitals are predicted to show the fastest growth among end users

Revolutionizing Eye Care: AI’s Breakthrough in the Scleral Lens Industry

AI is revolutionizing the scleral lens market by enhancing diagnostic precision and streamlining the lens fitting process. Advanced AI-powered imaging tools, such as topography and tomography systems, enable detailed mapping of the corneal and scleral surfaces. This data is processed using machine learning algorithms to recommend custom lens designs tailored to each patient’s unique eye anatomy. As a result, practitioners can achieve better fit accuracy, reduce trial-and-error fittings, and improve patient comfort and outcomes.

Additionally, AI is being integrated into tele-optometry and remote patient monitoring solutions. With AI-assisted diagnostics and digital health platforms, eye care providers can monitor lens performance, track patient compliance, and detect complications such as hypoxia or lens fogging in real-time. These innovations not only enhance clinical efficiency but also expand access to specialty lenses in underserved or remote regions, contributing to the overall growth of the scleral lens market.

Market Overview

The scleral lens market is experiencing steady growth due to its effectiveness in treating complex ocular conditions such as keratoconus, severe dry eye, and corneal irregularities. These large-diameter contact lenses vault over the cornea and rest on the sclera, offering enhanced comfort and vision correction. Rising awareness and the demand for specialized eye care have made scleral lenses a preferred choice in both developed and emerging markets.

Market Scope

Market Dynamics

Market Drivers

Key drivers include the growing prevalence of eye disorders, advancements in lens materials, and improved manufacturing technologies. The expansion of optical health services and increased referrals from ophthalmologists and optometrists also fuel market growth. Additionally, the shift toward personalized and specialty lenses supports long-term market demand.

Market Opportunities

The market offers opportunities in tele-optometry and AI-driven diagnostic tools, enabling more accurate fittings and expanding access to care. Rising investments in vision correction solutions and increasing adoption of scleral lenses for post-surgical vision rehabilitation also present strong potential for growth.

Market Challenges

Despite the benefits, scleral lenses remain costly compared to traditional lenses, limiting accessibility in low-income regions. Fitting complexity and the need for skilled professionals may also hinder broader adoption. Limited patient awareness in some regions continues to be a barrier.

Regional Insights

North America leads the market, holding the largest share in 2024 due to a well-established eye care infrastructure and high awareness. Asia Pacific is expected to experience the fastest CAGR during the forecast period, driven by improving healthcare facilities and growing investments in ophthalmic solutions. Europe also shows consistent growth, particularly in countries with strong public healthcare systems.

Scleral Lens Market Companies

• ABB Optical Group
• Alden Optical Laboratories
• Art Optical Contact Lens Inc.
• Bausch Health Companies Inc.
• Blanchard Lab
• Boston Sight
• Essilor
• SynergEyes
• TruForm Optics Inc.
• Valley Contax
• Visionary Optics

Latest Announcements by Market Leaders

• In February 2025, ABB Optical Group announced the launch of the Delta Scleral, the next generation of scleral contact lenses, which premiered at GSLS 2025. ABB also announced the launch of HydroPure MPS and HydroPure Lubricating Eye Drops for both soft and gas-permeable lenses. HydroPure is an exclusive product line for ECPs through ABB Optical Group.
• In February 2023, Visionary Optics announced the launch of  Europa Tangent, a new scleral lens that provides a customizable design and a three-zone step system for optimal fitting; according to the release, the lens design was based on clinical experience and analysis of data from more than 10,000 fittings.

Recent Developments

• In May 2024, Bausch + Lomb Corporation announced the U.S. launch of Zenlens ECHO, a non-prosthetic, custom scleral contact lens technology designed to fit a wide variety of corneal shapes and sizes, including patients who have advanced ocular conditions such as corneal degeneration and certain postoperative conditions.
• In February 2023, Visionary Optics launched Europa Tangent, a new scleral lens that provides a customizable design and a three-zone step system for optimal fitting. The lens design was based on clinical experience and analysis of data from more than 10,000 fittings.

Segments Covered in the Report

By Type

• Corneo-Scleral Lenses and Semi-Scleral Lenses
• Mini-Scleral Lenses
• Full Scleral Lenses

By Application

• Irregular Cornea
• Ocular Surface Disease
• Refractive Error
• Other Applications

By End-User

• Hospitals
• Eye Clinics
• Other End Users

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Also Read: Water for Injection Market 

Ready for more? Dive into the full experience on our website@ https://www.precedenceresearch.com/